Safety and Efficacy of HMI-203 in ERT-Treated Adults With MPS II
NCT05238324
·
clinicaltrials.gov ↗
PHASE1
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class
Stopped
Homology Medicines has discontinued development of this program.
Conditions
Mucopolysaccharidosis II
Interventions
BIOLOGICAL:
Genetic HMI-203
Sponsor
Homology Medicines, Inc